imidazole has been researched along with Long QT Syndrome in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Owens, RC | 1 |
| Nolin, TD | 1 |
1 review available for imidazole and Long QT Syndrome
| Article | Year |
|---|---|
Antimicrobial-associated QT interval prolongation: pointes of interest.
Topics: Anti-Infective Agents; Antifungal Agents; Biomarkers; Fluoroquinolones; Humans; Imidazoles; Ketolide | 2006 |